Search research articles
Contact Us
Filters
Showing results (161-170 of 171) with videos related to
Page
of 18
Sort By:
Vox Sanguinis
|
November 25, 2003
Current status of immunoprophylaxis with anti-D immunoglobin
C P Engelfriet, H W Reesink, W J Judd, et al.
Vox Sanguinis
|
December 17, 2008
Genotyping for red blood cell polymorphisms
C E van der Schoot, M de Haas, C P Engelfriet, et al.
Vox Sanguinis
|
August 25, 2001
Universal leucocyte-depletion of blood components: cell concentrates and plasma
C P Engelfriet, H W Reesink, R N Pietersz, et al.
Vox Sanguinis
|
September 12, 2007
Detection of bacterial contamination of platelet concentrates
R N I Pietersz, C P Engelfriet, H W Reesink, et al.
Vox Sanguinis
|
February 24, 2001
Quality assurance, quality control and accreditation
C P Engelfriet, H W Reesink, G G de Lange, et al.
Vox Sanguinis
|
December 12, 2007
Management of alloimmune thrombocytopenia
H H H Kanhai, L Porcelijn, C P Engelfriet, et al.
Vox Sanguinis
|
November 16, 2006
Prevention and diagnosis of delayed haemolytic transfusion reactions
C P Engelfriet, H W Reesink, R Fontão-Wendel, et al.
Vox Sanguinis
|
January 22, 2008
Occult hepatitis B infection in blood donors
H W Reesink, C P Engelfriet, G Henn, et al.
Vox Sanguinis
|
May 10, 2005
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003
J Coste, H W Reesink, C P Engelfriet, et al.
Vox Sanguinis
|
January 30, 2008
Biobanks of blood from donors and recipients of blood products
H W Reesink, C P Engelfriet, C A Hyland, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 171) with videos related to
Sort By:
Page
of 18
Vox Sanguinis
|
November 25, 2003
Current status of immunoprophylaxis with anti-D immunoglobin
C P Engelfriet, H W Reesink, W J Judd, et al.
Vox Sanguinis
|
December 17, 2008
Genotyping for red blood cell polymorphisms
C E van der Schoot, M de Haas, C P Engelfriet, et al.
Vox Sanguinis
|
August 25, 2001
Universal leucocyte-depletion of blood components: cell concentrates and plasma
C P Engelfriet, H W Reesink, R N Pietersz, et al.
Vox Sanguinis
|
September 12, 2007
Detection of bacterial contamination of platelet concentrates
R N I Pietersz, C P Engelfriet, H W Reesink, et al.
Vox Sanguinis
|
February 24, 2001
Quality assurance, quality control and accreditation
C P Engelfriet, H W Reesink, G G de Lange, et al.
Vox Sanguinis
|
December 12, 2007
Management of alloimmune thrombocytopenia
H H H Kanhai, L Porcelijn, C P Engelfriet, et al.
Vox Sanguinis
|
November 16, 2006
Prevention and diagnosis of delayed haemolytic transfusion reactions
C P Engelfriet, H W Reesink, R Fontão-Wendel, et al.
Vox Sanguinis
|
January 22, 2008
Occult hepatitis B infection in blood donors
H W Reesink, C P Engelfriet, G Henn, et al.
Vox Sanguinis
|
May 10, 2005
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003
J Coste, H W Reesink, C P Engelfriet, et al.
Vox Sanguinis
|
January 30, 2008
Biobanks of blood from donors and recipients of blood products
H W Reesink, C P Engelfriet, C A Hyland, et al.
Page
of 18